MEMO1 binds iron and modulates iron homeostasis in cancer cells.

Frederick S Vizeacoumar, Franco J Vizeacoumar, Michal T Boniecki, Martina Ralle, Marco Tonelli, Oleg Y Dmitriev, Jaala Patry, Natalia Dolgova, Eva-Maria E Uhlemann, Anjuman Ara, Paria Nouri, Syed A Abbas, Hussain Elhasasna, Andrew Freywald

Journal: eLife 2024;13():

PMID: 38640016

Abstract

Mediator of ERBB2-driven cell motility 1 (MEMO1) is an evolutionary conserved protein implicated in many biological processes; however, its primary molecular function remains unknown. Importantly, MEMO1 is overexpressed in many types of cancer and was shown to modulate breast cancer metastasis through altered cell motility. To better understand the function of MEMO1 in cancer cells, we analyzed genetic interactions of MEMO1 using gene essentiality data from 1028 cancer cell lines and found multiple iron-related genes exhibiting genetic relationships with MEMO1. We experimentally confirmed several interactions between MEMO1 and iron-related proteins in living cells, most notably, transferrin receptor 2 (2), mitoferrin-2 (), and the global iron response regulator IRP1 (). These interactions indicate that cells with high-MEMO1 expression levels are hypersensitive to the disruptions in iron distribution. Our data also indicate that MEMO1 is involved in ferroptosis and is linked to iron supply to mitochondria. We have found that purified MEMO1 binds iron with high affinity under redox conditions mimicking intracellular environment and solved MEMO1 structures in complex with iron and copper. Our work reveals that the iron coordination mode in MEMO1 is very similar to that of iron-containing extradiol dioxygenases, which also display a similar structural fold. We conclude that MEMO1 is an iron-binding protein that modulates iron homeostasis in cancer cells.

© 2024, Dolgova, Uhlemann, Boniecki et al.

Address: Department of Biochemistry, Microbiology and Immunology, University of Saskatchewan, Saskatoon, Canada.; Protein Characterization and Crystallization Facility, University of Saskatchewan, Saskatoon, Canada.; Department of Pathology and Laboratory Medicine, University of Saskatchewan, Saskatoon, Canada.; Department of Molecular and Medical Genetics, Oregon Health and Sciences University, Portland, United States.; National Magnetic Resonance Facility at Madison (NMRFAM), University of Wisconsin, Madison, United States.; Cancer Research Department, Saskatchewan Cancer Agency, Saskatoon, Canada.; Division of Oncology, University of Saskatchewan, Saskatoon, Canada.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.